Lucie Karayan-Tapon

Summary

Affiliation: CHU de Poitiers
Country: France

Publications

  1. pmc The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression
    A Ferru
    Laboratoire d Oncologie Moléculaire EA3805, PBS, Cité Hospitalière de La Milétrie, Avenue du Recteur Pineau 86021, Poitiers, France
    Br J Cancer 95:1670-7. 2006
  2. pmc EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients
    Claire Villalva
    INSERM U935, Poitiers University, Poitiers, France
    Cancer Med 2:296-304. 2013
  3. pmc An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
    François Ducray
    INSERM, U842, Lyon, F 69372 France
    Mol Cancer 9:234. 2010
  4. ncbi request reprint Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas
    J L Blanc
    Laboratory of Molecular Oncology, EA 2224, IBMIG, Poitiers, France
    J Neurooncol 68:275-83. 2004
  5. doi request reprint [Molecular biology of adult gliomas: some landmarks for neurosurgeons]
    M Wager
    Service de Neurochirurgie, tour Jean Bernard, CHU de Poitiers, 2, rue de la Miletrie, B P 577, 86021 Poitiers Cedex, France
    Neurochirurgie 54:529-44. 2008
  6. pmc Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study
    M Wager
    Neurosurgery Department, University Hospital, Poitiers, France
    Br J Cancer 98:1830-8. 2008
  7. pmc Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients
    M Wager
    Neurosurgery Department, University Hospital, Poitiers, France
    Br J Cancer 95:1062-9. 2006
  8. doi request reprint Altered expression of the gap junction protein connexin43 is associated with papillary thyroid carcinomas when compared with other noncancer pathologies of the thyroid
    Claudia Dominguez
    Department of Visceral Surgery, Jean Bernard Hospital, University Hospital Center CHU of Poitiers, Poitiers, France
    Thyroid 21:1057-66. 2011
  9. ncbi request reprint Expression of TAp73 and DeltaNp73 isoform transcripts in thyroid tumours
    A Ferru
    Laboratoire d Oncologie Moléculaire EA3805, PBS, Cité Hospitalière de La Milétrie, avenue du Recteur Pineau, 86021 Poitiers Cedex, France
    Eur J Surg Oncol 32:228-30. 2006
  10. pmc Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
    L Karayan-Tapon
    Universite de Poitiers, EA 3805, CHU de Poitiers, 2 rue de la Miletrie, BP 577, Poitiers F 86021, France
    Br J Cancer 99:1153-60. 2008

Collaborators

Detail Information

Publications11

  1. pmc The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression
    A Ferru
    Laboratoire d Oncologie Moléculaire EA3805, PBS, Cité Hospitalière de La Milétrie, Avenue du Recteur Pineau 86021, Poitiers, France
    Br J Cancer 95:1670-7. 2006
    ..However, these deregulations do not appear to be correlated to the clinical outcome and they could not be used as potential prognostic markers...
  2. pmc EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients
    Claire Villalva
    INSERM U935, Poitiers University, Poitiers, France
    Cancer Med 2:296-304. 2013
    ..These results raise the question of the variability of the brain metastatic potential of NSCLC cells in relation to the mutation pattern. ..
  3. pmc An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
    François Ducray
    INSERM, U842, Lyon, F 69372 France
    Mol Cancer 9:234. 2010
    ..The gene expression (n = 56) and genomic profiles (n = 67) of responders and non-responders to first-line chemotherapy or radiation therapy alone were compared on Affymetrix Plus 2 gene expression arrays and BAC CGH arrays...
  4. ncbi request reprint Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas
    J L Blanc
    Laboratory of Molecular Oncology, EA 2224, IBMIG, Poitiers, France
    J Neurooncol 68:275-83. 2004
    ..Our observations do not lead us to consider promoter methylation of MGMT gene as a prognostic factor of responsiveness to alkylating agents in glioblastomas...
  5. doi request reprint [Molecular biology of adult gliomas: some landmarks for neurosurgeons]
    M Wager
    Service de Neurochirurgie, tour Jean Bernard, CHU de Poitiers, 2, rue de la Miletrie, B P 577, 86021 Poitiers Cedex, France
    Neurochirurgie 54:529-44. 2008
    ..Consequently, the clinician must assimilate a large amount of information, raising the question of the genuine role of these biomarkers in the daily care of these patients...
  6. pmc Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study
    M Wager
    Neurosurgery Department, University Hospital, Poitiers, France
    Br J Cancer 98:1830-8. 2008
    ..This study confirms the prognostic value of several markers. However, the scattering of the values explained by tumour heterogeneity prevents their use in individual decision-making...
  7. pmc Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients
    M Wager
    Neurosurgery Department, University Hospital, Poitiers, France
    Br J Cancer 95:1062-9. 2006
    ..Our data are the first such molecular biology report regarding low-grade tumours and as such should be of help for sound decision-making...
  8. doi request reprint Altered expression of the gap junction protein connexin43 is associated with papillary thyroid carcinomas when compared with other noncancer pathologies of the thyroid
    Claudia Dominguez
    Department of Visceral Surgery, Jean Bernard Hospital, University Hospital Center CHU of Poitiers, Poitiers, France
    Thyroid 21:1057-66. 2011
    ..To verify their possible involvement in thyroid pathologies, the expression of connexin43 (Cx43), the major Cx in the human thyroid, was evaluated in a variety of diseases including cancer...
  9. ncbi request reprint Expression of TAp73 and DeltaNp73 isoform transcripts in thyroid tumours
    A Ferru
    Laboratoire d Oncologie Moléculaire EA3805, PBS, Cité Hospitalière de La Milétrie, avenue du Recteur Pineau, 86021 Poitiers Cedex, France
    Eur J Surg Oncol 32:228-30. 2006
    ..This study was aimed to determine p73 status in thyroid tumours...
  10. pmc Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
    L Karayan-Tapon
    Universite de Poitiers, EA 3805, CHU de Poitiers, 2 rue de la Miletrie, BP 577, Poitiers F 86021, France
    Br J Cancer 99:1153-60. 2008
    ..Moreover, in multivariate analysis, SEMA3G was found to be the only significant prognostic marker...
  11. ncbi request reprint Topoisomerase II alpha and telomerase expression in papillary thyroid carcinomas
    L Karayan-Tapon
    Laboratoire de Protéines et Inflammation, CHU La Miletrie, 86021 Poitiers Cedex, France
    Eur J Surg Oncol 30:73-9. 2004
    ..Altered topoisomerase II alpha (Topo II alpha) expression and telomerase activity (TA) reflect tumour cell growth and malignant transformation...